EUVIMEDEUVIMED entdecken
Crossref

Phenytoin Concentrations in Biological Fluids of Traumatic Brain Injury Patients

Atefeh Razavi, Ali Meshkini, Mohammad Reza Afshar Mogaddam, Behrouz Seyfinejad, Maryam Khoubnasabjafari

ImmunoAnalysis · 2025

DOI: 10.34172/ia.025.5099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoAnalysis, 2025. Verfasst von Atefeh Razavi und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aims to determine and compare phenytoin concentrations in cerebrospinal fluid (CSF), serum, and urine. In addition, it strives to investigate their inter-correlations to provide insight into alternative monitoring methods.

Methods

This study was conducted on 16 traumatic brain injury (TBI) patients admitted to the intensive care unit. Phenytoin concentrations were measured in CSF, serum, and urine samples using a liquid chromatography-tandem mass spectrometry. Statistical analysis assessed correlations between phenytoin levels across different samples and between concentrations and the received daily dose, age, and body mass index (BMI).

Results

Phenytoin concentrations varied significantly between CSF, serum, and urine, with serum levels being the highest. Correlation analyses revealed significant positive correlations between phenytoin CSF and serum levels (r=0.83, P=0.0005), serum and urine levels (r=0.73, P=0.003), and CSF and urine levels (r=0.64, P=0.013). Serum concentrations were not influenced by age or BMI. No significant correlation was observed between phenytoin levels and its daily dose.

Conclusion

This study demonstrated significant correlations between phenytoin levels in CSF and serum, suggesting that CSF could be a viable alternative for therapeutic drug monitoring (TDM) in TBI patients. However, urine concentrations were less reliable. Further studies with larger patient cohorts and different clinical settings are needed to validate these findings and explore the potential of CSF monitoring in routine clinical practice.

Zitieren

APA

Razavi, A., Meshkini, A., Mogaddam, M. R. A., Seyfinejad, B., & Khoubnasabjafari, M. (2025). Phenytoin Concentrations in Biological Fluids of Traumatic Brain Injury Patients. ImmunoAnalysis. https://doi.org/10.34172/ia.025.5099

Vancouver

Razavi A, Meshkini A, Mogaddam MRA, Seyfinejad B, Khoubnasabjafari M. Phenytoin Concentrations in Biological Fluids of Traumatic Brain Injury Patients. ImmunoAnalysis. 2025. doi:10.34172/ia.025.5099

BibTeX
@article{Razavi2025,
  author = {Razavi, Atefeh and Meshkini, Ali and Mogaddam, Mohammad Reza Afshar and Seyfinejad, Behrouz and Khoubnasabjafari, Maryam},
  title = {Phenytoin Concentrations in Biological Fluids of Traumatic Brain Injury Patients},
  journal = {ImmunoAnalysis},
  year = {2025},
  doi = {10.34172/ia.025.5099}
}
Kostenlos starten →